151 related articles for article (PubMed ID: 37365923)
41. Clinical usefulness of [18F]FDG PET-CT and CT/MRI for detecting nodal metastasis in patients with hypopharyngeal squamous cell carcinoma.
Shin NY; Lee JH; Kang WJ; Koh YW; Sohn B; Kim J
Ann Surg Oncol; 2015 Mar; 22(3):994-9. PubMed ID: 25201502
[TBL] [Abstract][Full Text] [Related]
42. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer.
Brink I; Schumacher T; Mix M; Ruhland S; Stoelben E; Digel W; Henke M; Ghanem N; Moser E; Nitzsche EU
Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1614-20. PubMed ID: 15258700
[TBL] [Abstract][Full Text] [Related]
43. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
Odalovic S; Stojiljkovic M; Sobic-Saranovic D; Pandurevic S; Brajkovic L; Milosevic I; Grozdic-Milojevic I; Artiko V
Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416
[TBL] [Abstract][Full Text] [Related]
44. A Combined Scoring Method Based on 18F-FDG PET/CT for Distinguishing Spinal Infection From Malignancy.
Chen J; Xue L; Li X; Xiong W
Spine (Phila Pa 1976); 2023 Feb; 48(4):270-277. PubMed ID: 36692156
[TBL] [Abstract][Full Text] [Related]
45. Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas.
Maccioni F; Alfieri G; Assanto GM; Mattone M; Gentiloni Silveri G; Viola F; De Maio A; Frantellizzi V; Di Rocco A; De Vincentis G; Pulsoni A; Martelli M; Catalano C
Radiol Med; 2023 May; 128(5):556-564. PubMed ID: 37145214
[TBL] [Abstract][Full Text] [Related]
46. Rare Findings of Gallbladder Metastasis From Cutaneous Melanoma on 18 F-FDG PET/CT Imaging.
Zhou J; Zhao Y
Clin Nucl Med; 2024 Mar; 49(3):253-254. PubMed ID: 38181300
[TBL] [Abstract][Full Text] [Related]
47. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
Ottenhof SR; Djajadiningrat RS; Versleijen MWJ; Donswijk ML; van der Noort V; Brouwer OR; Graafland NM; Vegt E; Horenblas S
Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842
[TBL] [Abstract][Full Text] [Related]
48. (18)F-FDG PET in small-cell cervical cancer: a prospective study with long-term follow-up.
Chen MY; Chou HH; Liu FY; Chen CY; Lin G; Yang LY; Pan YB; Jung SM; Wu RC; Huang YT; Tsai JC; Yen TC; Lai CH; Chang TC
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):663-74. PubMed ID: 26519293
[TBL] [Abstract][Full Text] [Related]
49. Benefits of
Wen G; Gu J; Zhou W; Wang L; Tian Y; Dong Y; Fu L; Wu H
Eur Radiol; 2020 Sep; 30(9):5089-5098. PubMed ID: 32346795
[TBL] [Abstract][Full Text] [Related]
50. Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes.
Vidiri A; Gangemi E; Ruberto E; Pasqualoni R; Sciuto R; Sanguineti G; Farneti A; Benevolo M; Rollo F; Sperati F; Spasiano F; Pellini R; Marzi S
PLoS One; 2020; 15(3):e0229611. PubMed ID: 32119697
[TBL] [Abstract][Full Text] [Related]
51. Primary Breast Lymphoma Mimicking Metastatic Breast Cancer on 18F-FDG PET-CT.
Usmani S; Albader FL; Marafi F; Elhaggracy RS
J Pak Med Assoc; 2022 Jun; 72(6):1241-1242. PubMed ID: 35751349
[TBL] [Abstract][Full Text] [Related]
52. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
[TBL] [Abstract][Full Text] [Related]
53. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
Zamagni E; Nanni C; Patriarca F; Englaro E; Castellucci P; Geatti O; Tosi P; Tacchetti P; Cangini D; Perrone G; Ceccolini M; Brioli A; Buttignol S; Fanin R; Salizzoni E; Baccarani M; Fanti S; Cavo M
Haematologica; 2007 Jan; 92(1):50-5. PubMed ID: 17229635
[TBL] [Abstract][Full Text] [Related]
54. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
Terroir M; Caramella C; Borget I; Bidault S; Dromain C; El Farsaoui K; Deandreis D; Grimaldi S; Lumbroso J; Berdelou A; Hadoux J; Hescot S; Hartl D; Baudin E; Schlumberger M; Leboulleux S
Thyroid; 2019 Oct; 29(10):1457-1464. PubMed ID: 31530235
[No Abstract] [Full Text] [Related]
55. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H
Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805
[TBL] [Abstract][Full Text] [Related]
56. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
[TBL] [Abstract][Full Text] [Related]
57. Cholesterol Granuloma Masquerading as Gallbladder Carcinoma on 18F-FDG PET/CT.
Fu Z; Chen X; Yang X; Li Q
Clin Nucl Med; 2019 Jun; 44(6):489-490. PubMed ID: 30829860
[TBL] [Abstract][Full Text] [Related]
58. Chondrosarcoma of the spine-a case report.
Simon S; Resch H; Lomoschitz F; Frank BJH; Kocijan R
Wien Med Wochenschr; 2023 Oct; 173(13-14):334-338. PubMed ID: 35119543
[TBL] [Abstract][Full Text] [Related]
59. FDG-PET-CT/MRI in head and neck squamous cell carcinoma: Impact on pretherapeutic N classification, detection of distant metastases, and second primary tumors.
Stadler TM; Morand GB; Rupp NJ; Hüllner MW; Broglie MA
Head Neck; 2021 Jul; 43(7):2058-2068. PubMed ID: 33729625
[TBL] [Abstract][Full Text] [Related]
60. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
Lee JW; Nam SB; Kim SJ
Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
